🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
This register study will collect the treatment information of the intracran...
Status
Unknown
Location
Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University
Start Date
2013-02
Trial ID
NCT01803685
Research objective: To compare the efficacy and safety of Capox + Bev versu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07383285
This prospective interventional clinical study aims to evaluate the safety ...
Status
Active Not Recruiting
Location
Libyan Biotechnology Research Center (LBTRC)
Start Date
2025-11-01
Trial ID
NCT07466576
Treatments Being Tested
This is a Phase II open study, not randomized with a neoadjuvant therapy,co...
Status
Completed
Location
Clínica Universitaria de Navarra
Start Date
2011-05
Trial ID
NCT01389440
Treatments Being Tested
We intend to investigate the clinical application of two emerging imaging m...
Status
Completed
Location
Mayo Clinic
Start Date
2016-03
Trial ID
NCT02705391
The purpose of this research study is to look at how tumors responds to a s...
Status
Completed
Location
Washington University School of Medicine
Start Date
2016-05-27
Trial ID
NCT02641691
Treatments Being Tested
This monocentric study registry records all cancer patients at the Charité ...
Status
Recruiting
Location
Clinic for Radio - Oncology and Radiotherapy
Start Date
2014-11-01
Trial ID
NCT05993910
Treatments Being Tested
Background:Moderate three week hypofractionated adjuvant radiotherapy sched...
Status
Recruiting
Location
Sanjoy Chatterjee
Start Date
2019-03-26
Trial ID
NCT03788213
Combined modality approach using Obitunuzumab and involved site low dose ir...
Status
Completed
Location
University of Tuebingen
Start Date
2018-04-24
Trial ID
NCT03341520
Treatments Being Tested